Abstract P6-10-07: CDK2 Inhibition with BLU-222 in Combination with Ribociclib Demonstrates Robust Antitumor Activity in Pre-Clinical Models of CDK4/6 Inhibitor-Naïve and -Resistant HR+/HER2- Breast Cancer
Cancer Research(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要